CVS
CVS Health Corporation
September 25, 2026 · intraday
- Rarity
- 1.55
- Peak move
- +5.00%
- Float cap
- $107.9B
CVS Health Corporation is a health solutions company that operates retail pharmacies, walk-in and primary care clinics, and a pharmacy benefits manager. Through its Aetna operations, it offers medical, pharmacy, dental, behavioral health, Medicare Advantage, Medicare Part D, and Medicaid coverage. It serves consumers, employers, and government-sponsored plans.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
9 events · 0 from SEC or newswire · 0 timed with the movereg_fd_disclosureCVS Health disclosed seven large-scale renewable energy investments since 2022, securing more than 969,000 MWh of clean energy and aiming for 50% renewable electricity by 2040.
- Key event
customer_lossCVS Health notified 340B covered entities that it is terminating their existing contract pharmacy and administrative agreements and will roll out new ones.
- Key event
peer_disclosureThe Blue Cross Blue Shield Association published a study finding that hospitals' growing use of AI coding tools raised medical complexity coding, adding an estimated $942 million in costs to BCBS plans from 2023 to 2025, with $653 million tied to secondary diagnoses and medically complex inpatient stays rising from 37% to 40%.
- Key event
institutional_flowEnvestnet Asset Management raised its CVS Health stake 80.9% in the second quarter, adding 1,554,354 shares to hold 3,475,264 shares worth about $359.5 million.
litigation_outcomeCVS Health agreed to a $20.5 million class-action settlement resolving allegations that it shared patients' personal and health data with third parties including Criteo via web trackers on its sites and app, with a final approval hearing set for Dec. 1, 2026.
product_launchCVS Health said its CVS Pharmacy and MinuteClinic locations across Tennessee are offering MMR vaccinations to eligible patients after the state health department confirmed nine measles cases.
regulatory_actionCVS Health, UnitedHealth Group and Kaiser Permanente submitted comment letters to CMS on Sept. 14 opposing a proposal in the 2027 Medicare physician fee schedule that would bar Medicare payment for remote patient monitoring performed by third-party contractors.
analyst_ratingUBS reiterated a Buy rating and $118 price target on CVS Health after a Q3 2026 end-of-quarter meeting with management.
bankruptcyA Texas bankruptcy judge approved the Chapter 11 wind-down plan for CVS Health subsidiary Omnicare after it sold its long-term care pharmacy operations to GenieRx Holdings for $250 million and settled a nearly $1 billion False Claims Act judgment with the Justice Department for $440 million.